Abstract
The nootropic compound nefiracetam was evaluated in 88 older rabbits in a 750-ms delay paradigm of eyeblink classical conditioning (EBCC). Rabbits (mean age=28.7 months) were assigned in groups of eight to one of six conditions in experiment 1: paired tone conditioned stimulus (CS)-corneal airpuff unconditioned stimulus (US) presentations and 1, 3, or 10 mg nefiracetam/kg or sterile saline vehicle; explicitly unpaired CS and US presentations and 3 mg nefiracetam/kg or sterile saline vehicle. Animals in the paired conditions received 10 daily sessions of 90 paired trials and animals in the unpaired conditions received 10 daily sessions of 180 unpaired CS and US presentations. The six conditions in experiment 2 were 5, 10, and 15 mg nefiracetam/kg and vehicle in 15 sessions of paired presentations; 10 mg nefiracetam/kg and vehicle in 15 sessions of unpaired conditioning. In both experiments 1 and 2, acquisition measured by trials to learning criterion was significantly faster at the 10 mg/kg dose of nefiracetam. In the repeated measures analyses comparing six doses in the paired conditions, all dependent measures [percentage conditioned responses (CRs), CR amplitude, and response latency] indicated significantly better conditioning in rabbits treated with 10 mg nefiracetam/kg, but this dose did not increase motor responding or responding in the unpaired condition. Nefiracetam facilitated acquisition of EBCC in older rabbits. EBCC is performed poorly by older humans and is seriously impaired in Alzheimer's disease. These preclinical data in an animal model with clear parallels in humans suggest that nefiracetam may prove effective as a cognition enhancer in clinical trials.
Similar content being viewed by others
References
Anonymous (1990) Proposed international nonproprietary names (Prop. INN): List 64. World Health Organization Drug Information 4:203
Barnes CA (1983) The physiology of the senescent hippocampus. In: Seifert W (ed) Neurobiology of the hippocampus. Academic Press, New York, pp 87–108
Bartus RT, Flicker C, Dean RL (1983) Logical principles for the development of animal models of age-related memory impairments. In: Crook T, Ferris S, Bartus RT (eds) Assessment for geriatric psychopharmacology. Mark Powley Associates, New Canaan, Conn., pp 263–299
Berger TW (1984) Long-term potentiation of hippocampal synaptic transmission affects rate of behavioral learning. Science 224:627–630
Berger TW, Thompson RF (1978a) Identification of pyramidal cells as the critical elements in hippocampal neuronal plasticity during learning. Proc Natl Acad Sci 75:1572–1576
Berger TW, Thompson RF (1978b) Neuronal plasticity in the limbic system during classical conditioning of the rabbit nictitating membrane response. I. The hippocampus. Brain Res 145:323–346
Berger TW, Alger BE, Thompson RF (1976) Neuronal substrates of classical conditioning in the hippocampus. Science 192:483–485
Berger TW, Rinaldi P, Weisz DJ, Thompson RF (1983) Single unit analysis of different hippocampal cell types during classical conditioning of the rabbit nictitating membrane response. J Neurophysiol 59:1197–1219
Brizzee KR, Ordy JM (1979) Age pigments, cell loss and hippocampal function. Mech Aging Dev 9:143–162
Coffin JM, Woodruff-Pak DS (1993) Delay classical conditioning in young and older rabbits: initial acquisition and retention at 12 and 18 months. Behav Neurosci 107:61–72
Coffin JM, Papka M, Woodruff-Pak DS (1991) Trace classical conditioning in Alzheimer's disease. Soc Neurosci Abstr 17:698
Coffin JM, Ferrante LS, Woodruff-Pak DS (1992) Delay classical conditioning has a higher sensitivity for Alzheimer's disease than trace. Soc Neurosci Abstr 18:736
Coffin JM, Trojanowski J, Woodruff-Pak DS (1993) Cerebellar nucleus interpositus and Purkinje cell numbers related to age differences in eyeblink classical conditioning. Soc Neurosci Abstr 19:180
Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190
Daum I, Channon S, Canavan AGM (1989) Classical conditioning in patients with severe memory problems. J Neurol Neurosurg Psychiatry 52:47–51
Daum I, Channon S, Polkey CE, Gray JA (1991) Classical conditioning after temporal lobe lesions in man:impairment in conditional discrimination. Behav Neurosci 105:396–408
Drugs of the Future (1989) DM-9384 (nefiracetam) 14:17–19
Drugs of the Future (1992) DM-9384 (nefiracetam) 17:55–56
Gormezano I (1966) Classical conditioning. In: Sidowski JB (ed) Experimental methods and instrumentation in psychology. McGraw-Hill, New York, pp 385–420
Graves CA, Solomon PR (1985) Age related disruption of trace but not delay classical conditioning of the rabbit's nictitating membrane response. Behav Neurosci 99:88–96
Hall TC, Miller KH, Corsellis JAN (1975) Variations in the human Purkinje cell population according to age and sex. Neuropathol Appl Neurobiol 1:267–292
Harrison J, Buchwald J (1983) Eyeblink conditioning deficits in the old cat. Neurobiol Aging 4:45–51
Harvey JA, Gormezano I, Cool-Hauser VA (1983) Effects of scopolamine and methylscopolamine on classical conditioning of the rabbit nictitating membrane response. J Pharmacol Exp Ther 225:42–49
Ito M (1984) The cerebellum and neural control. Raven Press, New York
Landfield PW (1988) Hippocampal neurobiological mechanisms of age-related memory dysfunction. Neurobiol Aging 9:571–580
Lavond DG, Steinmetz JE (1989) Acquisition of classical conditioning without cerebellar cortex. Behav Brain Res 33:113–164
Li Y-T, Woodruff-Pak DS, Kazmi A, Kem WR (1992) Mecamylamine delays acquisition of the classically conditioned NM response but does not affect nicotinic receptor binding in rabbit brain. Soc Neurosci Abstr 18:343
Lye RH, O'Boyle DJ, Ramsden RT, Schady W (1988) Effects of a unilateral cerebellar lesion on the acquisition of eye-blink conditioning in man. J Physiol (Lond) 403:58P
Nakamura J, Higashi H, Nishi S, Nakazawa Y (1991) DM-9384, a pyrrolidone derivative, protects the membrane dysfunction induced by deprivation of oxygen and glucose in guinea-pig hippocampal neurons in vitro. Biol Psychiatry 29 [Suppl 11]: pp 29–36
Patterson MM, Romano AR (1987) The rabbit in Pavlovian conditioning. In: Gormezano I, Prokasy WF, Thompson RF (eds) Classical conditioning. Erlbaum, Hillsdale, N.J., pp 1–36
Powell DA, Buchanan SL, Hernandez LL (1981) Age related changes in classical (Pavlovian) conditioning in the New Zealand albino rabbit. Exp Aging Res 7:453–465
Salvatierra AT, Berry SD (1989) Scopolamine disruption of septohippocampal activity and classical conditioning. Behav Neurosci 103:715–721
Sarter M (1991) Taking stock of cognition enhancers. Trends Pharmacol Sci 12:456–461
Sarter M, Hagen J, Dudchenko P (1992) Behavioral screening for cognition enhancers: from indiscriminate to valid testing, part I. Psychopharmacology 107:144–159
Sasse DC, Woodruff-Pak DS (1990) Classical conditioning in young and older rabbits in delay and trace paradigms with a 750 msec CS-US interval. Soc Neurosci Abstr 16:841
Sasse DK, Coffin JM, Woodruff-Pak DS (1991) Age differences in rabbits in the delay classical conditioning paradigm using 400 and 750 msec CS-US intervals. Soc Neurosci Abstr 17:1140
Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB (1976) Progressive dendritic changes in the human limbic system. Exp Neurol 53:420–430
Solomon PR, Solomon SD, Vander Schaaf E, Perry HE (1983) Altered activity in the hippocampus is more detrimental to classical conditioning than removing the structure. Science 220:329–331
Solomon PR, Pomerleau D, Bennett L, James J, Morse DL (1989a) Acquisition of the classically conditioned eyeblink response in humans over the life span. Psychol Aging 4:34–41
Solomon PR, Stowe GT, Pendlebury WW (1989b) Disrupted eyelid conditioning in a patient with damage to the cerebellar inputs. Behav Neurosci 103:898–902
Solomon PR, Levine R, Bein P, Pendlebury WW (1991) Classical eyeblink conditioning in Alzheimer's disease patients. Neurobiol Aging 12:283–287
Sudo K, Hashimoto K, Fujimaki Y, Tachizawa H (1988) Disposition and metabolism of DM-9384, a cyclic GABA derivative, in the rat, dog, and monkey. Psychopharmacology 96[Suppl]: Abst 32.02.05
Thompson RF (1986) The neurobiology of learning. Science 233:941–947
Thompson RF (1990) Neural mechanisms of classical conditioning in mammals. Philos Trans R Soc Lond [Biol] 329:161–170
Watabe S, Yamaguchi H Ashida S (1990) Effects of DM-9384, a new cognition-enhancing agent, on cholinergic system in rat cortex. Soc Neurosci Abstr 16:137
Weiss C, Thompson RF (1991) The effects of age on eyeblink conditioning in the freely moving Fischer-344 rat. Neurobiol Aging 12:249–254
Woodruff-Pak DS (1988) Aging and classical conditioning: parallel studies in rabbits and humans. Neurobiol Aging 9:511–522
Woodruff-Pak DS (1990) Mammalian models of learning, memory, and aging. In: Birren JE, Schaie KW (eds) Handbook of the psychology of aging, 3rd edn. Academic Press, New York, pp 235–257
Woodruff-Pak DS (1993) Eyeblink classical conditioning in H.M.: delay and trace paradigms. Behav Neurosci 107:911–925
Woodruff-Pak DS, Thompson RF (1988) Classical conditioning of the eyeblink response in the delay paradigm in adults aged 18–83 years. Psychol Aging 3:219–229
Woodruff-Pak DS, Lavond DG, Logan CG, Thompson RF (1987) Classical conditioning in 3-, 30, and 45-month-old rabbits: behavioral learning and hippocampal unit activity. Neurobiol Aging 8:101–108
Woodruff-Pak DS, Cronholm JF, Sheffield JB (1990a) Purkinje cell number related to rate of classical conditioning. NeuroReport 1:165–168
Woodruff-Pak DS, Finkbiner RG, Sasse DK (1990b) Eyeblink conditioning discriminates Alzheimer's patients from non-demented aged. NeuroReport 1:45–49
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woodruff-Pak, D.S., Li, YT. Nefiracetam (DM-9384): effect on eyeblink classical conditioning in older rabbits. Psychopharmacology 114, 200–208 (1994). https://doi.org/10.1007/BF02244837
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244837